Evidence map›Paper›PMID 34047035›Full record

ArticleInternal medicine journal2021

COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement.

Georgia McCaughan, Pietro Di Ciaccio, Michelle Ananda-Rajah, Nicole Gilroy, Raina MacIntyre, Benjamin Teh, Robert Weinkove, Jennifer Curnow, Jeff Szer, Anoop K Enjeti and 25 more

Open access · bronzeAbstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  2. Article
  3. Review
  4. Review
  5. COVID-19: looking backward.Internal medicine journal · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 3 countries.

Georgia McCaughan *Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-4838-9022
Pietro Di Ciaccio *Department of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.ORCID 0000-0002-9282-8619
Michelle Ananda-RajahDepartment of Infectious Diseases, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Nicole GilroyCentre for Infectious Diseases and Clinical Microbiology, Westmead Hospital, Sydney, New South Wales, Australia.
Raina MacIntyreBiosecurity Program, The Kirby Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia.
Benjamin TehNational Centre for Infections in Cancer, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.
Robert WeinkoveWellington Blood and Cancer Centre, Capital and Coast District Health Board, Wellington, New Zealand.
Jennifer CurnowDepartment of Haematology, Westmead Hospital, Sydney, New South Wales, Australia.
Jeff SzerClinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.ORCID 0000-0001-6783-2301
Anoop K EnjetiNSW Health Pathology, John Hunter Hospital, Newcastle, New South Wales, Australia.
David M RossDepartment of Hematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, Australia.
Stephen MulliganFaculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Judith TrotmanFaculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-8009-4593
Michael DickinsonClinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.ORCID 0000-0002-1492-5966
Hang QuachFaculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Phillip ChoiACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.ORCID 0000-0001-9340-8125
Mark N PolizzottoDepartment of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.
Constantine S TamClinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
P Joy HoFaculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.
Matthew KuFaculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-9289-1335
Gareth GregoryDepartment of Haematology, Monash Health, Melbourne, Victoria, Australia.
Shane GangatharanFaculty of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Greg HapgoodDepartment of Haematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.ORCID 0000-0002-7980-8496
Tara CochraneDepartment of Haematology, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
Chan CheahFaculty of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Simon GibbsDepartment of Haematology, Eastern Health, Melbourne, Victoria, Australia.
Andrew WeiDepartment of Clinical Hematology, The Alfred Hospital, Melbourne, Victoria, Australia.
Anna JohnstonDepartment of Haematology, The Royal Hobart Hospital, Hobart, Tasmania, Australia.
Matthew GreenwoodFaculty of Medicine, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-3667-2613
H Miles PrinceClinical Haematology, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Maya LatimerHaematology Department, The Canberra Hospital, Canberra, Australian Capital Territory, Australia.
Leanne BerkahnDepartment of Haematology, The Auckland City Hospital, Auckland, New Zealand.
Joel WightFaculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Tasman ArmytageDepartment of Haematology, Gosford Hospital, Gosford, New South Wales, Australia.
Nada HamadDepartment of Haematology, St Vincent's Hospital, Sydney, New South Wales, Australia.ORCID 0000-0001-7929-1450
The University of Sydney · AUUNSW Sydney · AUThe Royal Melbourne Hospital · AUThe University of Melbourne · AUThe University of Western Australia · AUAustralian National University · AUCanberra Hospital · AUEastern Health · AUGosford Hospital · AUGriffith University · AUJohn Hunter Hospital · AUMalaghan Institute of Medical Research · NZMonash Alfred Psychiatry Research centre · AUMonash Health · AUPeter MacCallum Cancer Centre · AUPrincess Alexandra Hospital · AUSouth Australia Pathology · AUThe Alfred Hospital · AUUniversity of Auckland · NZUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Australia and New Zealand have achieved excellent community control of COVID-19 infection. In light of the imminent COVID-19 vaccination roll out in both countries, representatives from the Haematology Society of Australia and New Zealand and infectious diseases specialists have collaborated on this consensus position statement regarding COVID-19 vaccination in patients with haematological disorders. It is our recommendation that patients with haematological malignancies, and some benign haematological disorders, should have expedited access to high-efficacy COVID-19 vaccines, given that these patients are at high risk of morbidity and mortality from COVID-19 infection. Vaccination should not replace other public health measures in these patients, given that the effectiveness of COVID-19 vaccination, specifically in patients with haematological malignancies, is not known. Given the limited available data, prospective collection of safety and efficacy data of COVID-19 vaccination in this patient group is a priority.

Indexed as

COVID-19HematologyAustraliaConsensusCOVID-19 VaccinesHumansNew ZealandProspective StudiesSARS-CoV-2VaccinationCOVID-19 VaccinesCOVID-19haematologyleukaemialymphomaplasma cellvaccination

Identifiers

PMID34047035
PMCPMC8206846
OpenAlexW3165840851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.